GOLDEN, Colo. – October 20, 2015 – Today, PharmaJet, the maker of innovative, needle-free injector technology, announced partnerships with four distributors including ABO Pharmaceuticals, FFF Enterprises, McKesson and Moore Medical, to offer the PharmaJet Needle-Free Injection System for needle-free flu shots1 throughout the United States. The product is currently available for purchase.
“Entering the market this year, the PharmaJet Needle-Free Injector has been well received by patients and health care providers alike. In fact, 93 percent of patients and 87 percent of health care providers reported that they would choose the PharmaJet needle-free option again,” said Ron Lowy, PharmaJet Chairman and CEO. “We are excited to partner with ABO, FFF, McKesson and Moore Medical to assist in our nationwide rollout of PharmaJet needle-free flu shots, and we anticipate that the increased availability of the device will enable greater influenza vaccination compliance. The product is currently available in 32 states. These distribution agreements will expand the availability to additional retail pharmacies, occupational and industrial healthcare professionals, colleges and universities, correctional facilities, and municipalities and government agencies.”
- Refer to Instructions for Use and the individual device & drug/biologic labeling for prescribing information to ensure safe injections and to review
About PharmaJet, Inc.
Based in Golden, Colorado, PharmaJet was founded with the goal of reducing the use of medical needles throughout the world. PharmaJet’s innovative Stratis® Injector has U.S. FDA 510(k) marketing clearance, CE Mark, and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously. In August 2014, the PharmaJet Needle-Free Injector was approved for delivery of an influenza vaccine to deliver needle-free flu shots. The PharmaJet Needle-Free Injector is easy-to-use and eliminates needlestick injuries, needle reuse and cross contamination, and helps reduce sharps waste disposal.